Rotterdam criteria 832 (35.7) (ref.) | AE-PCOS criteria 1123 (48.2) | NIH criteria 281 (12.1) | Other criteria 43 (1.8) | Don’t know 49 (2.1) | |||||
---|---|---|---|---|---|---|---|---|---|
n (%) | n (%) | Adjusted OR (95%CI) | n (%) | Adjusted OR (95%CI) | n (%) | Adjusted OR (95%CI) | n (%) | Adjusted OR (95%CI) | |
Gender | |||||||||
Female (ref.) | 799 (35.5) | 1091 (48.5) | 1.000 | 272 (12.1) | 1.000 | 41 (1.8) | 1.000 | 46 (2.0) | 1.000 |
male | 33 (41.8) | 32 (40.5) | 0.824 (0.490,1.387) | 9 (11.4) | 0.707 (0.327,1.530) | 2 (2.5) | 1.450 (0.320,6.567) | 3 (3.8) | 2.100 (0.559,7.884) |
Age (years) | |||||||||
18–25 | 10 (38.5) | 12 (46.2) | 0.964 (0.383,2.425) | 2 (7.7) | 0.340 (0.070,1.650) | 0 (0) | - | 2 (7.7) | 3.039 (0.473,19.5080 |
26–35 (ref.) | 159 (31.5) | 244 (48.4) | 1.000 | 79 (15.7) | 1.000 | 10 (2.0) | 1.000 | 12 (2.4) | 1.000 |
36–45 | 343 (34.6) | 513 (51.7) | 1.050 (0.723,1.526) | 100 (10.1) | 0.828 (0.481,1.423) | 18 (1.8) | 1.024 (0.315,3.335) | 18 (1.8) | 2.334 (0.890,6.119) |
46–55 | 282 (39.2) | 317 (44.1) | 91 (12.7) | 1.378 (0.689,2.754) | 13 (1.8) | 0.703 (0.159,3.102) | 16 (2.2) | 5.385 (0.341,21.631) | |
≥56 | 38 (43.7) | 37 (42.5) | 1.118 (0.700,1.783) 1.024 (0.538,1.949) | 9 (10.3) | 1.048 (0.394,2.792) | 2 (2.3) | 0.774 (0.105,5.701) | 1 (1.1) | 2.952 (0.286,30.497) |
Hospital classification | |||||||||
Tertiary (ref.) | 443 (46.6) | 360 (37.9) | 1.000 | 120 (12.6) | 1.000 | 17 (1.8) | 1.000 | 11 (1.2) | 1.000 |
Secondary | 310 (29.2) | 577 (54.3)* | 2.012 (1.627,2.488) | 132 (12.4)* | 1.557 (1.141,2.124) | 17 (1.6) | 1.300 (0.625,2.705) | 26 (2.4)* | 3.203 (1.442,7.115) |
Primary | 26 (17.3) | 97 (64.7)* | 3.724 (2.331,5.950) | 15 (10.0) | 1.962 (0.989,3.891) | 5 (3.3)* | 4.194 (1.360,12.932) | 7 (4.7)* | 7.959 (2.593,24.426) |
Others | 53 (32.1) | 89 (53.9)* | 1.820 (1.240,2.671) | 14 (8.5) | 0.917 (0.495,1.736) | 4 (2.4) | 1.753 (0.549,5.602) | 5 (3.0) | 2.777 (0.853,9.042) |
Specialty | |||||||||
Ge-ObGyn (ref.) | 757 (34.4) | 1090 (49.5) | 1.000 | 264 (12.0) | 1.000 | 41 (1.9) | 1.000 | 49 (2.2) | 1.000 |
Re-ObGyn | 75 (59.1) | 33 (26.0)* | 0.513 (0.328,0.802) | 17 (13.4) | 0.833 (0.465,1.493) | 2 (1.6) | 0.696 (0.155,3.132) | 0 (0) | - |
Years in post (y) | |||||||||
≤5 (ref.) | 74 (32.3) | 100 (43.7) | 1.000 | 43 (18.8) | 1.000 | 4 (1.7) | 1.000 | 8 (3.5) | 1.000 |
6–10 | 116 (30.4) | 196 (51.4) | 1.171 (0.763,1.797) | 46 (12.1) | 0.676 (0.386,1.183) | 8 (2.1) | 1.346 (0.360,5.035) | 15 (3.9) | 0.246 (0.059,1.032) |
11–20 | 243 (33.4) | 387 (53.2) | 1.194 (0.718,1.985) | 80 (11.0) | 0.680 (0.339,1.364) | 10 (1.4) | 0.971 (0.191,4.930) | 7 (1.0) | 1.448 (0.473,4.433) |
>20 | 399 (40.3) | 440 (44.4) | 0.733 (0.416,1.292) | 112 (11.3)* | 0.405 (0.182,0.902) | 21 (2.1) | 1.378 (0.238,7.960) | 19 (1.9) | 0.252 (0.053,1.193) |
Years of PCOS caring (y) | |||||||||
<1 (ref.) | 19 (17.0) | 58 (51.8) | 1.000 | 20 (17.9) | 1.000 | 3 (2.7) | 1.000 | 12 (10.7) | 1.000 |
1–5 | 290 (29.9) | 521 (53.7) | 0.617 (0.354,1.077) | 119 (12.3)* | 0.446 (0.225,0.884) | 19 (2.0) | 0.436 (0.113,1.677) | 21 (2.2)* | 0.144 (0.058,0.357) |
6–10 | 288 (42.0) | 293 (42.8)* | 0.430 (0.239,0.773) | 84 (12.3)* | 0.412 (0.197,0.864) | 9 (1.3) | 0.230 (0.051,1.044) | 11 (1.6)* | 0.113 (0.038,0.336) |
11–20 | 180 (43.4) | 184 (44.3) | 0.554 (0.299,1.026) | 39 (9.4)* | 0.349 (0.156,0.781) | 7 (1.7) | 0.324 (0.064,1.635) | 5 (1.2)* | 0.096 (0.025,0.362) |
>20 | 55 (37.7) | 67 (45.9) | 0.747 (0.372,1.503) | 19 (13.0) | 0.580 (0.232,1.451) | 5 (3.4) | 0.757 (0.131,4.367) | 0 (0.0) | - |
Number of patients with PCOS treated annually | |||||||||
1-50 (ref.) | 482 (29.8) | 859 (53.1) | 1.000 | 2 (12.5) | 1.000 | 30 (1.9) | 1.000 | 44 (2.7) | 1.000 |
50-200 | 244 (45.6) | 215 (40.2)* | 0.417 (0.282,0.616) | 62 (11.6) | 0.755 (0.530,1.076) | 10 (1.9) | 0.894 (0.401,1.995) | 4 (0.7) | 0.407 (0.137,1.204) |
>200 | 106 (60.2) | 49 (27.8)* | 0.673 (0.531,0.854) | 17 (9.7)* | 0.535 (0.298,0.961) | 3 (1.7) | 0.625 (0.167,2.338) | 1 (0.6) | 0.395 (0.050,3.127) |